000739:SHE
Apeloa Pharmaceutical Co Ltd
CNÂ¥23,42
arrow_downward
-1,64%(-0,39) 1 HR
16 Okt, 15.04.48 GMT+8 · CNY
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk 000739...
Pembukaan
CNÂ¥24,04
Tinggi
CNÂ¥24,76
Rendah
CNÂ¥23,09
Kapitalisasi pasar
27,13Â M
Volume rata-rata
16,27Â jt
Volume
15,09Â jt
Dividen
1,61%
Dividen per kuartal
CNÂ¥0,09
Tanggal tanpa dividen
8 Okt 2026
Rasio P/E
31,78
Harga tinggi dalam 52 minggu terakhir
CNÂ¥28,50
Harga rendah dalam 52 minggu terakhir
CNÂ¥14,89
EPS
CNÂ¥0,74
Saham beredar
1,16Â M
Jumlah karyawan
7Â rb
Pembukaan
CNÂ¥24,04
Tinggi
CNÂ¥24,76
Rendah
CNÂ¥23,09
Kapitalisasi pasar
27,13Â M
Volume rata-rata
16,27Â jt
Volume
15,09Â jt
Dividen
1,61%
Dividen per kuartal
CNÂ¥0,09
Tanggal tanpa dividen
8 Okt 2026
Rasio P/E
31,78
Harga tinggi dalam 52 minggu terakhir
CNÂ¥28,50
Harga rendah dalam 52 minggu terakhir
CNÂ¥14,89
EPS
CNÂ¥0,74
Saham beredar
1,16Â M
Jumlah karyawan
7Â rb
Artikel berita
Dari sumber web dan partner berita
Vietnam.vn
·
1 hari yang lalu
Indeks S&P 500 mengalami penurunan mingguan paling tajam sejak Juni 2026.
BeInCrypto
·
10 jam yang lalu
Michael Burry Peringatkan tentang ‘Supervolcano’ di Pasar Saham
Pluang
·
2 jam yang lalu
VIX melonjak 21,45% saat S&P 500 turun 1,1%, Bi...
gadget.qoo10.co.id
·
17 jam yang lalu
Wall Street Ditekan Saham AI Dan Minyak, Nasdaq Merosot Lebih Dari 4 Persen
Profil
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
Tentang Apeloa Pharmaceutical Co Ltd